1 month ago
The Food and Drug Administration earlier this period cleared Ozempic shaper Novo Nordisk to marketplace nan weight-loss supplier Wegovy for bosom benefits. Medicare now will screen Wegovy prescriptions for patients pinch a precocious consequence of bosom disease. Both brands Ozempic and Wegovy are based connected nan anti-diabetic medicine semaglutide. File Photo by Ida Marie Odgaard/EPA-EFE
March 21 (UPI) -- Medicare now will screen Wegovy aft nan Food and Drug Administration cleared nan shaper to marketplace nan celebrated weight-loss supplier arsenic a curen for bosom problems.
A Centers for Medicare and Medicaid Services spokesperson told NBC News Thursday that Medicare, which historically has been barred from paying for weight-loss drugs, now will salary for Wegovy if it is being utilized to trim nan consequence of bosom disease. The supplier still will not beryllium covered if it is only being utilized for weight management.
The CMS said it reconsidered its sum of Wegovy aft nan FDA expanded approval for nan supplier to beryllium prescribed to group who are astatine consequence of bosom complications.
Anti-obesity narcotics that get support to dainty conditions different than excess weight can beryllium covered successful Medicare Part D medicine plans. Reducing bosom illness consequence is simply a medically accepted usage nether national law.
The FDA approved Wegovy shaper Novo Nordisk's exertion to database cardiovascular benefits earlier this period aft reviewing a 17,000-patient study, which showed group who took Wegovy had a 20% little consequence of a cardiac arena than group who took a placebo.
Lawrence Gostin, head of nan O'Neill Institute for National and Global Health Law astatine Georgetown University, told NBC News that Medicare's sum of Wegovy could beryllium financially risky. The supplier carries a database value of astir $1,200.
The Congressional Budget Office connected Wednesday maintained its position that sum of Wegovy would summation wide national spending, but nan costs would dangle connected nan existent usage of nan supplier nether eligible recipients and nan long of their treatment.
The Treat and Reduce Obesity Act, which would assistance Medicare's regularisation connected sum of weight-loss drugs, has bipartisan support, but it's improbable to summation traction successful Congress without clearer penetration connected really that would impact national spending.
Wegovy is judge to beryllium celebrated for Medicare patients, arsenic a December survey from nan University of Michigan National Poll connected Healthy Aging recovered 3 successful 4 adults deliberation Medicare should screen medicine weight-loss drugs.
Novo Nordisk has said it is gradually expanding its proviso of Wegovy complete nan people of this twelvemonth to support up pinch accrued request amid an ongoing shortage.
